zs pharma stock
ZS PHARMA, INC. (ZSPH) stock price, charts, trades & the US's most popular discussion forums. 26 talking about this. The company valuation of ZS Pharma, Inc, according to these metrics is way below the market valuation of its sector. ZS Pharma is a privately held specialty pharmaceutical company based in Coppell, Texas, and Menlo Park, CA. Nabisco plant to close, … Rooms Shows Rankings Earnings Calendar Shop. Recurring Once. The agent name of this company is: C T CORPORATION SYSTEM , and company's status is listed as Active now. China gives approval for broader use of Sinovac vaccine . ZS Pharma is registered under the ticker NASDAQ:ZSPH . Read full article. For financial reporting, their fiscal year ends on December 31st. Monthly Subscription. Read Next All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Free trial . ZS PHARMA INC : Cours de bourse, graphiques, cotations, conseils boursiers, données financières, analyses et actualités en temps réel de l'action ZS PHARMA INC | Nasdaq For all future releases Just for the upcoming release Send me a reminder 1 trading day before Sign Up. Free forex prices, toplists, indices and lots more. 3 Quality Buy and Hold Stocks for Long Term Investors. RiverVest and Salem Partners are the most recent investors. ZS Pharma, Inc. (US:ZSPH) has 6 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). Follow Zs Pharma I's earnings. Free trial. ZS Pharma. Watch. En novembre 2015, AstraZeneca acquiert ZS Pharma, une entreprise pharmaceutique américaine, pour 2,7 milliards de dollars [9]. The company valuation of ZS Pharma, Inc, according to these metrics is way below the market valuation of its peer group. AstraZeneca has agreed to acquire ZS Pharma and its promising therapy for hyperkalaemia. ZS Pharma stock roared higher after the Bloomberg report, closing with a 28.4% gain at $74.73 that pushed the company's market cap closer to $2 billion. ZS Pharma dropped 3.1 percent on Thursday to close at $63.31, taking its market value to $1.59 billion. Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB. Big Cap Pro. Search / Go. September 24, 2014, 4:46 AM. Its core focus is the research and development of highly selective ion-trap therapies to treat serious medical conditions. This website uses cookies so that we can provide you with the best user experience possible. for only. ZS Pharma: Astra Zeneca to Acquire ZS Pharma at $90 per Share-DARN (ZSPH, $90) Posted by Larry Smith on Nov 8, 2015 • ( 2 ) O n Friday, November 9, 2015 Astra Zeneca entered into a definitive agreement to buy ZS Pharma in an all-cash tender offer for all outstanding shares of ZS Pharma common stock at a price of $90 per share. ZS Pharma has raised a total of $123M in funding over 5 rounds. LiveStock & Poultry Medicine , Vaccines & Nutraceutical Products ZS Pharma, Inc. is registered with the U.S. Security and Exchange Commission and incorporated in the state of Delaware. ZS Pharma (ZSPH) in Focus: Stock Moves 10.7% Higher. S&P 500 3,886.83. Upon completion, ZS Pharma, which has around 200 employees across three sites in California, Texas and Colorado, will become a wholly owned subsidiary of AstraZeneca. for only. ZS Pharma, Inc. was a big mover last session, as the company saw its shares rise nearly 11% on the day.The move came on solid volume too with far more shares changing hands than in a normal session. Founder of ZS Pharma, Inc. and Renibus Therapeutics, Inc., Alvaro F. Guillem currently occupies the position of Chairman & Chief Executive Officer at Renibus Therapeutics, Inc., Chairman at OncoNano Medicine, Inc. and President of ZS Pharma, Inc. View ZSPH's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at MarketBeat. ZS Pharma, Inc is primarely in the business of pharmaceutical preparations. Researching ZS Pharma (NASDAQ:ZSPH) stock? Cancel. Le même mois, AstraZeneca vend des licences sur certains médicaments concernant la maladie de Crohn à Perrigo pour 380 millions de dollars [10]. ZS Pharma is a brand of AstraZeneca listed on the Frankfurt stock exchange. ZS PHARMA, INC. was registered on Oct 06, 2016 as a stock type company located at 1100 PARK PL STE 300, SAN MATEO, CA 94403 . ZS Pharma (ZSPH) stock is up this morning after the company had its price target raised at JPMorgan to $75 from $57. ZS Pharma NASDAQ Updated Jan … ZS Pharma is funded by 10 investors. Their latest funding was raised on Jul 18, 2014 from a Post-IPO Debt round. The move came on pretty good volume too. ZS Pharma (NASDAQ: ZSPH) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers on Benzinga. Trending now . View real-time stock prices and stock quotes for a full financial overview. Berenberg Bank raised shares of Zscaler from a “hold” rating to a “buy” rating […] MarketBeat: Week in Review 2/1 – 2/5. ZS Pharma (ZSPH) stock is spiking in late morning trading on Friday, after the biopharmaceutical company agreed to be acquired by AstraZeneca (AZN) for $2.7 billion. DOW 0.00%. $33.03. ZS Pharma is part of the Healthcare business sector. He is also on the board of Nanoscope Therapeutics, Inc. ZS PHARMA, INC. (ZSPH) stock price, charts, trades & the US's most popular discussion forums. Follow ZSPH. 89.98 0.00 (0.0%) Upgrade to Real-Time Afterhours (Closed) Best deals to access real time data! The ISIN, the company's International Securities Identification Number, is GB0009895292. DOW 31,148.24. A number of other analysts also recently issued reports on the stock. Get instant access to a free live streaming chart of the Zs Pharma I Stock. Under the terms of the agreement, AstraZeneca will acquire all of the outstanding capital stock of ZS Pharma for $90 per share in an all-cash transaction, or approximately $2.7 billion in aggregate transaction value. Zs Pharma, Inc. has … Their stock opened with $27.00 in its Jun 19, 2014 IPO. NASDAQ 0.00%. ZS | Complete Zscaler Inc. stock news by MarketWatch. S&P 500 0.00%. Real-time trade and investing ideas on ZS Pharma ZSPH from the largest community of traders and investors. Zacks Equity Research . Real-time trade and investing ideas on ZS Pharma ZSPH from the largest community of traders and investors. The N/A ratio of ZS Pharma, Inc, is significantly lower than the average of its sector (Pharmaceuticals): 3.33. ZSPH / ZS Pharma, Inc. financial ratios include Market Cap, Enterprise Value, Book Value, Quick Ratio, Current Ratio, NCAV, EBITDA, Profit Margin, Operating Margin, Return on Invested Capital (ROIC), Return on Assets (ROA), Return on Equity (ROE), Piotroski F-Score, Altman Z-Score, Beneish M Score and Kaplan-Zingales KZ-Index. Zscaler (NASDAQ:ZS) was upgraded by equities research analysts at TheStreet from a “d” rating to a “c-” rating in a research note issued to investors on Tuesday, TheStreetRatingsTable reports. $52.04. Stock Ticker Lookup. ZS Pharma, Inc. ( ZSPH ) saw a big move last session, as the company's shares fell nearly 10% on the day. Cookie information is stored in your browser and performs functions such as recognisin Small Cap Basic. ZS PHARMA, INC. Stock Price . Frequency. Latest Stock Picks Investing Basics ... Stock Advisor launched in February of 2002. Upon completion, ZS Pharma, which has around 200 employees across three sites in California, Texas and Colorado, will become a wholly owned subsidiary of AstraZeneca. QQQ 331.36. Monthly Subscription. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. ZS Pharma Inc Stock Institutional Ownership and Insider Ownership - : the historical trend of stock ownership among institutions and insiders. Largest shareholders include . This reverses the recent downtrend for the company, as the stock has lost over 8% since Aug 26. Free forex prices, toplists, indices and lots more. ZSPH : ZS Pharma, Inc. SEC CIK 0001459266 Ticker: ZSPH. Log In. The ZS Pharma brand, founded in 2008 (United States), has more than 546 sister brands and more than 22 510 competing brands. Under the terms of the agreement, AstraZeneca will acquire all of the outstanding capital stock of ZS Pharma for $90 per share in an all-cash transaction, or approximately $2.7 billion in aggregate transaction value.